Yousif Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Yousif Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,686	Closed	-$1.02M	–	1999
2022 Q4	$1.02M	Sell	30,686 -4,565	-13%	-$147K	0.01%	1145
2022 Q3	$1.11M	Sell	35,251 -593	-2%	-$19.2K	0.02%	1133
2022 Q2	$1.09M	Sell	35,844 -3,890	-10%	-$105K	0.01%	1190
2022 Q1	$1.03M	Sell	39,734 -225	-0.6%	-$5.35K	0.01%	1344
2021 Q4	$815K	Buy	+39,959	New	+$766K	0.01%	1462

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yousif Capital Management's VIVO Position: Q1 2023 in Review

Yousif Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 30,686 shares — an estimated $1.02M sold.

Yousif Capital Management first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $1.11M in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Yousif Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Yousif Capital Management sold 30,686 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.02M.
Yousif Capital Management first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
Yousif Capital Management's Meridian Bioscience Inc position peaked at $1.11M in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Yousif Capital Management's 13F filing for Q1 2023, filed 2 May 2023.